Apoptosis and Cancer Therapy 2006
DOI: 10.1002/9783527619665.ch1
|View full text |Cite
|
Sign up to set email alerts
|

The role of CD95/CD95 Ligand Signaling in Apoptosis and Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2007
2007
2008
2008

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 151 publications
0
2
0
Order By: Relevance
“…Moreover, it is known that PKC is crucial for T-cell development and activation of the transcription factors AP-1 and NF-B (48,59). These transcription factors are major regulators of CD95L expression (26). In addition, AP-1 and NF-B are ROS sensitive (17).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, it is known that PKC is crucial for T-cell development and activation of the transcription factors AP-1 and NF-B (48,59). These transcription factors are major regulators of CD95L expression (26). In addition, AP-1 and NF-B are ROS sensitive (17).…”
Section: Discussionmentioning
confidence: 99%
“…Twelve cell death receptors including TNF-R1, CD95 (Fas), DR3, TRAIL-R1 (tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptor 1), TRAIL-R2, DR6 (death receptor 6), DcR2 (decoy receptor 2), DcR3, osteoprotegrin (OPG), oectodysplasin receptor (EDA-R), and nerve growth factor receptor (NGF-R), six death ligands TNF, CD95L (FasL), TL1A, TRAIL, EDA, and NGF have been characterized in various cellular systems (280). However, the results regarding these death receptors/ligands are limited to Fas-FasL.…”
Section: Extrinsic Receptor-mediated Apoptosis Pathwaysmentioning
confidence: 99%